Cabaletta Bio
CABA
66 hedge funds and large institutions have $68.9M invested in Cabaletta Bio in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 14 closing their positions.
371% more call options, than puts
Call options by funds: $1.81M | Put options by funds: $385K
36% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 14
27% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 15
8% more funds holding
Funds holding: 61 → 66 (+5)
8.46% less ownership
Funds ownership: 84.1% → 75.64% (-8.5%)
67% less capital invested
Capital invested by funds: $211M → $68.9M (-$142M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Samlyn Capital
New York
|
+$11M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$10M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$5.04M |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$3.64M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$11.3M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.5M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.34M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$4.88M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$3.68M |
CABA Hedge Fund Activity: Q4 2021 in Review
66 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Cabaletta Bio (CABA) for Q4 2021, worth a combined $68.9M — down 67% from $211M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new CABA positions and 14 closed out — a net gain of 5 holders — while 19 added to existing stakes and 15 trimmed.
The largest buyer was Samlyn Capital, adding an estimated $11M. The largest seller was Boxer Capital, cutting an estimated $11.3M.
- 66 institutional investors held Cabaletta Bio (CABA) as of Q4 2021, up from 61 in Q3 2021.
- Funds reported $68.9M of Cabaletta Bio stock for Q4 2021, down 67% quarter-over-quarter.
- 19 funds opened new Cabaletta Bio positions in Q4 2021 and 14 closed out, a net change of +5 holders.
- The largest Cabaletta Bio buyer in Q4 2021 was Samlyn Capital, an estimated $11M added.
- The largest Cabaletta Bio seller in Q4 2021 was Boxer Capital, an estimated $11.3M sold.
Based on aggregated 13F filings for Q4 2021.